Home  >  Products  >  PSMD9 (proteasome (prosome, macropain) 26S subunit, non-ATPase, 9) Blocking Peptide (the C terminal of PSMD9)(100ug)
PSMD9 (proteasome (prosome, macropain) 26S subunit, non-ATPase, 9) Blocking Peptide (the C terminal of PSMD9)(100ug)

PSMD9 (proteasome (prosome, macropain) 26S subunit, non-ATPase, 9) Blocking Peptide (the C terminal of PSMD9)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-PSMD9 Antibody, made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP59344
Size: 100ug
Weight: 25kDa
Gene: 5715
Format: Lyophilized powder
Target: The 26S proteasome is a multicatalytic proteinase complex with a highly ordered structure composed of 2 complexes, a 20S core and a 19S regulator. The 20S core is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. The 19S regulator is composed of a base, which contains 6 ATPase subunits and 2 non-ATPase subunits, and a lid, which contains up to 10 non-ATPase subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a non-ATPase subunit of the 19S regulator.
Alternative names: MGC8644; Rpn4; p27